Skip to main content
Log in

The importance of subcapsular anesthesia in the anesthesiological management for thyroid radiofrequency ablation

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Radiofrequency ablation is a minimally invasive procedure alternative to surgery to treat benign thyroid nodules causing compressive symptoms. Tolerability of this procedure, aimed at treatment of benign conditions, is fundamental. In this study, we evaluated if local anesthesia should be enough to reduce both hospital costs and sedation-related risks for the patient, avoiding deep sedation and presence of the anesthesiologist. From July 2017 to August 2018, 14 consecutive patients (mean age 60.1 years) were treated and divided in two groups: Group A (7 patients) underwent systemic sedoanalgesia (intravenous remifentanil/fentanyl ± intravenous midazolam ± intravenous acetaminophen/nonsteroidal anti-inflammatory drugs) + subcutaneous anesthesia (lidocaine), with anesthesiologist. Group B (7 patients) underwent mild systemic sedoanalgesia (oral solution morphine sulfate + intravenous midazolam + intravenous acetaminophen) + both subcutaneous and subcapsular anesthesia (mepivacaine + bupivacaine), without anesthesiologist. Tolerability, sedation grade (Ramsay scale), total opioid dose, complications, and results at 12 months were analyzed and compared. Mean tolerability was 9.4 in group A and 8.9 in group B (p: 0.786). Mean sedation grade was 3.86 in group A and 2.71 in group B (p: 0.016). Mean total opioid dose was 70.9 mg in group A and 10 mg in group B (p:0.00015). No complications were observed. At 12 months, mean volume reduction was 56.1% in the group A and 60% in the group B. In thyroid radiofrequency ablation, subcapsular anesthesia can decrease both total opioid dose and level of patient’s sedation without significant differences in tolerability, allowing to perform ablation without the anesthesiologist.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am. 2007;36(3):707–35.

    Article  CAS  Google Scholar 

  2. Kamran SC, Marqusee E, Kim MI, Frates MC, Ritner J, Peters H, et al. Thyroid nodule size and prediction of cancer. J Clin Endocrinol Metab. 2013;98(2):564–70.

    Article  CAS  Google Scholar 

  3. Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, Paciaroni A, et al. The natural history of benign thyroid nodules. JAMA. 2015;313(9):926–354.

    Article  CAS  Google Scholar 

  4. Nakamura H, Hirokawa M, Ota H, Kihara M, Miya A, Miyauchi A. Is an increase in thyroid nodule volume a risk factor for malignancy? Thyroid. 2015;25(7):804–11.

    Article  Google Scholar 

  5. Jeong WK, Baek JH, Rhim H, Kim YS, Kwak MS, Jeong HJ, Lee D, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008;18(6):1244–50.

    Article  Google Scholar 

  6. Moalem J, Suh I, Duh QY. Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature. World J Surg. 2008;32(7):1301–12.

    Article  Google Scholar 

  7. Serpell JW, Phan D. Safety of total thyroidectomy. ANZ J Surg. 2007;77(1–2):15–9.

    Article  Google Scholar 

  8. Rosato L, Avenia N, Bernante P, De Palma M, Gulino G, Nasi PG, et al. Complications of thyroid surgery: analysis of a multicentric study on 14934 patients operated on in Italy over 5 years. World J Surg. 2004;28(3):271–6.

    Article  Google Scholar 

  9. Afolabi AO, Ayandipo OO, Afuwape OO. A fifteen year experience of total thyroidectomy for the management of simple multinodular goitres in a low medium income Country. S Afr J Surg. 2016;54(4):40–5.

    CAS  PubMed  Google Scholar 

  10. Bergenfelz A, Jansson S, Kristoffersson A, Mårtensson H, Reihnér E, Wallin G, et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbecks Arch Surg. 2008;393(5):667–73.

    Article  CAS  Google Scholar 

  11. Kim YJ, Baek JH, Ha EJ, Lim HK, Lee JH, Sung JY, et al. Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors. Eur Radiol. 2012;22(7):1573–8.

    Article  Google Scholar 

  12. Sui WF, Li JY, Fu JH. Percutaneous laser ablation for benign thyroid nodules: a meta-analysis. Oncotarget. 2017;8(47):83225–36.

    Article  Google Scholar 

  13. De Bernardi IC, Floridi C, Muollo A, Giacchero R, Dionigi GL, Reginelli A, et al. Vascular and interventional radiology radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: literature review. Radiol Med. 2014;119(7):512–20.

    Article  Google Scholar 

  14. Pompili G, Borelli A, Panella S, Masu A, et al. Microwave ablation for thyroid nodules: a new string to the bow for percutaneous treatments? Gland Surg. 2016;5(6):553–8.

    Article  Google Scholar 

  15. Lang BH, Wu ALH. The efficacy and safety of high-intensity focused ultrasound ablation of benign thyroid nodules. Ultrasonography. 2018;37(2):89–97.

    Article  Google Scholar 

  16. Jung SL, Baek JH, Lee JH, Shong YK, Sung JY, Kim KS, et al. Efficacy and safety of radiofrequency ablation for benign thyroid nodules: a prospective multicenter study. Korean J Radiol. 2018;19(1):167–74.

    Article  Google Scholar 

  17. Baek JH, Lee JH, Sung JY, Bae JI, Kim KT, Sim J, et al. Complications encountered in the treatment of benign thyroid nodules with us-guided radiofrequency ablation: a multicenter study. Radiology. 2012;262(1):335–42.

    Article  Google Scholar 

  18. Deandrea M, Trimboli P, Garino F, Mormile A, Magliona G, Ramunni MJ, et al. Long term efficacy of a single session rfa of benign thyroid nodules: a longitudinal 5-year observational study. J Clin Endocrinol Metab. 2019;104:3751–6.

    Article  Google Scholar 

  19. Deandrea M, Garino F, Alberto M, Garberoglio R, Rossetto R, Bonelli N, et al. Radiofrequency ablation for benign thyroid nodules according to different ultrasound features: an Italian multicentre prospective study. Eur J Endocrinol. 2019;180(1):79–877.

    Article  CAS  Google Scholar 

  20. Zhang B, Moser M, Zhang E, Zhang WJ. Radiofrequency ablation technique in the treatment of liver tumours: review and future issues. J Med Eng Technol. 2013;37(2):150–9.

    Article  CAS  Google Scholar 

  21. Wagstaff P, Ingels A, Zondervan P, de la Rosette JJ, Laguna MP. Thermal ablation in renal cell carcinoma management: a comprehensive review. Curr Opin Urol. 2014;24(5):474–82.

    Article  Google Scholar 

  22. Alexander ES, Dupuy DE. Lung cancer ablation: technologies and techniques. Semin Intervent Radiol. 2013;30(2):141–50.

    Article  Google Scholar 

  23. Nardi F, Basolo F, Crescenzi A, Fadda G, Frasoldati A, Orlandi F, et al. Italian consensus for the classification and reporting of thyroid cytology. J Endocrinol Invest. 2014;37(6):593–9.

    Article  Google Scholar 

  24. Baek JH, Lee JH, Valcavi R, Pacella CM, Rhim H, Na DG. Thermal ablation for benign thyroid nodules: radiofrequency and laser. Korean J Radiol. 2011;12:525–40.

    Article  Google Scholar 

  25. Morelli F, Ierardi AM, Pompili G, Sacrini A, Biondetti P, Angileri SA, et al. Cooled tip radiofrequency ablation of benign thyroid nodules: preliminary experience with two different devices. Gland Surg. 2018;7(2):67–79.

    Article  Google Scholar 

  26. Ramsay MAE, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alpaxalone-alphadolone. BMJ. 1974;2:656–9.

    Article  CAS  Google Scholar 

  27. Patanwala AE, Duby J, Waters D, Erstad BL. Opioid conversions in acute care. Ann Pharmacother. 2007;41(2):255–66.

    Article  CAS  Google Scholar 

  28. Ashburn MA, Lipman AG. Principles of analgesic use in the treatment of acute pain and chronic cancer pain. 5th ed. Glenview, IL: American Pain Society; 2003.

    Google Scholar 

  29. Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, editor. Goodman & Gillman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw Hill; 2001. p. 569–661.

    Google Scholar 

  30. The National Cancer Institute (2010) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Bethesda. Approved after October 1, 2009.

  31. Bernardi S, Dobrinja C, Carere A, Giudici F, Calabrò V, Zanconati F, et al. Patient satisfaction after thyroid RFA versus surgery for benign thyroid nodules: a telephone survey. Int J Hyperthermia. 2018;15:1–9.

    Google Scholar 

  32. Bernardi S, Dobrinja C, Fabris B, Bazzocchi G, Sabato N, Ulcigrai V, et al. Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol. 2014;2014:934595.

    Article  Google Scholar 

  33. Wang JF, Wu T, Hu KP, Xu W, Zheng BW, Tong G, et al. Complications following radiofrequency ablation of benign thyroid nodules: a systematic review. Chin Med J. 2017;130(11):1361–70.

    Article  Google Scholar 

  34. Kelly EF, Leveillee RJ. Image guided radiofrequency ablation for small renal masses. Int J Surg. 2016;36(Pt C):525–32.

    Article  Google Scholar 

  35. de Boer HD, Detriche O, Forget P. Opioid-related side effects: postoperative ileus, urinary retention, nausea and vomiting, and shivering. A review of the literature. Best Pract Res Clin Anaesthesiol. 2017;31(4):499–504.

    Article  Google Scholar 

Download references

Funding

This study was not supported by any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. Morelli.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was also approved by our Institutional Review Board (“gruppo di studio endocrinologico dell’Ospedale San Paolo”; protocol number: 2017-T435).

Informed consent

Consent for publication was obtained for every individual person’s data included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Morelli, F., Ierardi, A.M., Biondetti, P. et al. The importance of subcapsular anesthesia in the anesthesiological management for thyroid radiofrequency ablation. Med Oncol 37, 22 (2020). https://doi.org/10.1007/s12032-020-01347-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-020-01347-z

Keywords

Navigation